Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Wednesday Dec 13, 2023
Wednesday Dec 13, 2023
touchEXPERT OPINIONS for touchONCOLOGY
Two oncologists summarize the latest US and European guidelines for the treatment of recurrent/metastatic cervical cancer and a nurse practitioner considers key safety considerations for immunotherapy and targeted treatments.
The experts
- Dr David O’Malley - James Comprehensive Cancer Center, Columbus, OH, USA
- Dr Domenica Lorusso - La Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy,
- Courtney Arn – The Ohio State University, Columbus, OH, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Merck and Co., Inc and Seagen Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncologyime.org/guideline-management-recurrent-metastatic-cervical-cancer
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.